Jobs / United States / Novartis Pharmaceuticals Corporation
Lead Central Monitor
Novartis Pharmaceuticals Corporation · 🇺🇸 3 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Novartis Pharmaceuticals Corporation
The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Novartis Pharmaceuticals Corporation →
About the role
Salary Range: €63,600.00 - €118,000.00 Job Description Summary Role Type: Hybrid Working, #LI-Hybrid Primary Location: Barcelona, Spain Other Locations: London, United Kingdom; Dublin, Ireland Relocation Support: This role is based in Barcelona, Spain. Novartis is unable to offer relocation support: please only apply if accessible. What if your leadership could transform how clinical trial risks are identified, understood, and managed across a global development portfolio? As Lead Central Monitor, you will lead and develop a team of Central Monitors while shaping monitoring strategies that protect patient safety, trial quality, and data integrity. Working across clinical, data, and risk-surveillance teams, you will turn complex information into actionable insights, strengthen risk-based monitoring practices, and help advance the Central Monitoring capability at Novartis. Job Description Key Responsibilities • Lead and develop a team of Central Monitors, building capability, engagement, and consistently high performance. • Shape central and site monitoring strategies tailored to program, study, and Development Unit risks. • Oversee trial-data surveillance, risk reviews, signal detection, and insight generation using Central Monitoring technology. • Translate complex risk signals into actionable insights that enable Clinical Trial Teams to investigate and resolve issues. • Partner with clinical, data, and risk-surveillance teams to implement effective monitoring and risk-mitigation approaches. • Guide protocol development, risk assessment, and the design of study-specific Key Risk Indicators and thresholds. • Ensure monitoring activities support clinical data integrity, regulatory compliance, audit readiness, and timely issue resolution. • Drive continuous improvement through analytics, technology, innovation, lessons learned, and Risk-Based Quality Management. Essential Requirements • University degree in Life Sciences, Business, Operations, or a related discipline. • At least seven years of recent pharmaceutical or contract research organisation experience, including experience in clinical research. • At least five years of experience in central or site monitoring, clinical data analytics, data management, or a related discipline. • At least three years of recent people-management or team-leadership experience, with proven ability to develop high-performing teams. • Strong understanding of clinical trial development, study execution, protocols, study risks, and clinical trial risk-management processes. • Experience with centralised monitoring, Key Risk Indicators, Quality Tolerance Limits, and Risk-Based Quality Management approaches. • Strong knowledge of Good Clinical Practice, International Council for Harmonisation standards, and relevant health-authority requirements. • Strong analytical, digital, communication, and problem-solving skills, with the ability to interpret complex data and influence stakeholders in a global matrix environment. Desirable Requirements • Advanced university degree. • Extensive knowledge of a relevant therapeutic area. • Experience using artificial intelligence, analytics, or other digital approaches to support transformation. • Manager-of-managers experience and a track record of developing diverse, high-performing teams. Benefits & Rewards At Novartis, we’re committed to reimagining medicine together - and rewarding the people who make it happen. Expected Annual Base Salary Range for role: €63,600 to €118,000 The base salary offered is determined based on gender-neutral objectives, such as relevant skills, competencies and experience in accordance with the Novartis pay setting policy and upon joining Novartis will be reviewed periodically. In addition